It is likely to be rolled out in the national Covid vaccination...
Category:
Health
Latest
“Country’s Covid positivity rate declining week-on-week…” Health Ministry
The average daily cases during the week ending December 21, India...
Research shows significant cardiovascular benefits at 6,000 daily walking steps at any pace
The meta-analysis of 15 studies involving nearly 50,000 people from...
Tokyo Olympics at risk if coronavirus mutates, gets stronger:Japan adviser
“I think the virus is mutating all the time … it may be a much stronger virus that triggers a second wave,” Kiyoshi Kurokawa, a prominent Japanese government adviser,told Reuters. “The Olympics may be postponed again, but I can’t predict.”
Positive news on Oxford/AstraZeneca COVID-19 vaccine could come Thursday:report
AstraZeneca’s experimental vaccine is probably the world’s leading candidate and most advanced in terms of development, the World Health Organization’s chief scientist said in June.
The company has signed agreements with governments around the globe to supply the vaccine should it be cleared for use.
India’s tech hub Bengaluru, other towns back in lockdown amid COVID-19 surge
In all, India has 906,752 cases of the novel coronavirus with 28,498 new infections reported on Tuesday, according to data from the federal health ministry, the third highest total in the world behind Brazil and the United States.
South African regulator cautions insurers over rejection of virus claims
A Cape Town court on June 26 ruled in favor of a restaurant seeking payment from Momentum Metropolitan Ltd.’s Guardrisk Insurance Co. Guardrisk is “in the process of engaging with our legal team to study the judgment and consider the next steps,” a representative said.
India’s COVID-19 tally crosses 9 lakh with 28,498 fresh cases; death toll climbs to 23,727
The march of coronavirus infection in the country has picked up pace with the number of cases increasing by more than 26,000 for the fifth consecutive day. It took 110 days for the COVID-19 cases in the country to reach one lakh and just 56 days more to go past the nine-lakh mark.
Around 63.02 per cent of patients have recovered so far.
India has now less stunted children but more obese adults
More Indian adults became obese between 2012-16, the report said.
The number of adults (18 years and older) who are obese grew from 25.2 million in 2012 to 34.3 million in 2016, growing from 3.1 per cent to 3.9 per cent.
Human clinical trials for Covid-19 vaccine initiated in India:ICMR
The Drugs Controller General of India (DCGI) has permitted two vaccines — one developed by Bharat Biotech International Limited in collaboration with the Indian Council of Medical Research and another one by ZydasCadila Healthcare Ltd to go in for the first and second phase of human clinical trials.
There are two Indian vaccine candidates that have undergone successful toxicity studies in rats, mice and rabbits and these data was submitted to the DCGI, following which both got clearance to start an early phase human trials earlier this month, Bhargava said at a press briefing.
Network Hospitals have to provide cashless facility to policyholders:IRDAI
,it is clarified that the policyholders are entitled to cashless facility at all such network providers (hospital) with whom the Insurance company/TPA has entered into an agreement in accordance to the norms of SLA.
In the event of denial of cashless facility at any such enlisted network providers (hospitals) the aggrieved policyholders may send a complaint to the concerned insurance company.
Record spike of 28,701 COVID-19 cases takes India’s tally to 8,78,254
Death toll climbed to 23,174 with 500 people succumbing to the infection, according to the Union Health Ministry data.
Around 63.01 per cent of patients have recovered so far”
Glenmark cuts price of COVID-19 drug favipiravir version to $1 per tablet
Glenmark last month received Indian regulatory approval to make and sell anti-flu drug favipiravir, which is manufactured under the brand name Avigan by a unit of Japan’s Fujifilm Holdings Corp.
Glenmark had priced FabiFlu at 103 rupees per tablet earlier, making it one of the cheapest COVID-19 treatment available in the country.
“Glenmark’s price reduction aims to make FabiFlu further accessible for COVID-19 patients across the country,” the company said in a statement